Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD for young adults with mood disorder and cannabis use disorder
ACTRN12616001001482Phase 2Terminated
- Sponsor
- St Vincent's Hospital Melbourne
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in affective disorder and cannabis use disorder (CUD) comparing Cannabidiol + psychotherapy with Placebo + psychotherapy (2 arms). Primary endpoints: Recruitment rate, Adverse events during treatment and 1 more. Started Feb 2022; status: terminated.
02
Drugs
cannabidiol
03
Conditions
affective disordercannabis use disorder (CUD)
Beyond the preview
Go deeper on ACTRN12616001001482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001001482.